Fin
Echo
Markets
Dashboard
Search
Fear & Greed
Tools
Watchlist
Budget
Context
Upcoming
Notifications
Upcoming
Research
News
Market Events
Economy
New
SEC Filings
Finecho Content
New
Fin
Echo
Markets
Dashboard
Search
Fear & Greed
Tools
Watchlist
Budget
Context
Upcoming
Notifications
Upcoming
Research
News
Market Events
Economy
New
SEC Filings
Finecho Content
New
HOLLANDER DAVID
Private
CIK: 1793796
Location
DURHAM, NC
Insider Of
3
Name & Role
Position
Tenure
Holdings
AERIE PHARMACEUTICALS INC
Chief R&D Officer
Since Nov 2019
—
KIORA PHARMACEUTICALS INC
—
Since Dec 2021
—
REVANCE THERAPEUTICS, INC.
CMO & Global Therapeutics Lead
Since Feb 2024
—
AERIE PHARMACEUTICALS INC
Position
Chief R&D Officer
Tenure
Since Nov 2019
Holdings
—
KIORA PHARMACEUTICALS INC
Position
—
Tenure
Since Dec 2021
Holdings
—
REVANCE THERAPEUTICS, INC.
Position
CMO & Global Therapeutics Lead
Tenure
Since Feb 2024
Holdings
—